Literature DB >> 24705941

Discoidin domain receptors: a proteomic portrait.

Leo K Iwai1, Maciej T Luczynski, Paul H Huang.   

Abstract

The discoidin domain receptors (DDRs) are collagen-binding receptor tyrosine kinases that have been implicated in a number of fundamental biological processes ranging from growth and development to immunoregulation. In this review, we examine how recent proteomic technologies have enriched our understanding of DDR signaling mechanisms. We provide an overview on the use of large-scale proteomic profiling and chemical proteomics to reveal novel insights into DDR therapeutics, signaling networks, and receptor crosstalk. A perspective of how proteomics may be harnessed to answer outstanding fundamental questions including the dynamic regulation of receptor activation kinetics is presented. Collectively, these studies present an emerging molecular portrait of these unique receptors and their functional role in health and disease.

Mesh:

Substances:

Year:  2014        PMID: 24705941     DOI: 10.1007/s00018-014-1616-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  91 in total

1.  Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1.

Authors:  Christian Hansen; Paul Greengard; Angus C Nairn; Tommy Andersson; Wolfgang F Vogel
Journal:  Exp Cell Res       Date:  2006-09-09       Impact factor: 3.905

2.  Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.

Authors:  Peter S Hammerman; Martin L Sos; Alex H Ramos; Chunxiao Xu; Amit Dutt; Wenjun Zhou; Lear E Brace; Brittany A Woods; Wenchu Lin; Jianming Zhang; Xianming Deng; Sang Min Lim; Stefanie Heynck; Martin Peifer; Jeffrey R Simard; Michael S Lawrence; Robert C Onofrio; Helga B Salvesen; Danila Seidel; Thomas Zander; Johannes M Heuckmann; Alex Soltermann; Holger Moch; Mirjam Koker; Frauke Leenders; Franziska Gabler; Silvia Querings; Sascha Ansén; Elisabeth Brambilla; Christian Brambilla; Philippe Lorimier; Odd Terje Brustugun; Aslaug Helland; Iver Petersen; Joachim H Clement; Harry Groen; Wim Timens; Hannie Sietsma; Erich Stoelben; Jürgen Wolf; David G Beer; Ming Sound Tsao; Megan Hanna; Charles Hatton; Michael J Eck; Pasi A Janne; Bruce E Johnson; Wendy Winckler; Heidi Greulich; Adam J Bass; Jeonghee Cho; Daniel Rauh; Nathanael S Gray; Kwok-Kin Wong; Eric B Haura; Roman K Thomas; Matthew Meyerson
Journal:  Cancer Discov       Date:  2011-06       Impact factor: 39.397

Review 3.  Transmembrane collagen receptors.

Authors:  Birgit Leitinger
Journal:  Annu Rev Cell Dev Biol       Date:  2011-05-13       Impact factor: 13.827

4.  A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.

Authors:  Jiannong Li; Uwe Rix; Bin Fang; Yun Bai; Arthur Edwards; Jacques Colinge; Keiryn L Bennett; Jingchun Gao; Lanxi Song; Steven Eschrich; Giulio Superti-Furga; John Koomen; Eric B Haura
Journal:  Nat Chem Biol       Date:  2010-02-28       Impact factor: 15.040

5.  Actinomycin D identified as an inhibitor of discoidin domain receptor 2 interaction with collagen through an insect cell based screening of a drug compound library.

Authors:  Kauser Siddiqui; Geun Woong Kim; Dong Hoon Lee; Hae Ryun Shin; Eun Gyeong Yang; Nam Taek Lee; Beom-Seok Yang
Journal:  Biol Pharm Bull       Date:  2009-01       Impact factor: 2.233

6.  Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients.

Authors:  Tingting Ren; Jian Zhang; Jing Zhang; Xinping Liu; Libo Yao
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

7.  Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

Authors:  Klarisa Rikova; Ailan Guo; Qingfu Zeng; Anthony Possemato; Jian Yu; Herbert Haack; Julie Nardone; Kimberly Lee; Cynthia Reeves; Yu Li; Yerong Hu; Zhiping Tan; Matthew Stokes; Laura Sullivan; Jeffrey Mitchell; Randy Wetzel; Joan Macneill; Jian Min Ren; Jin Yuan; Corey E Bakalarski; Judit Villen; Jon M Kornhauser; Bradley Smith; Daiqiang Li; Xinmin Zhou; Steven P Gygi; Ting-Lei Gu; Roberto D Polakiewicz; John Rush; Michael J Comb
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

8.  Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.

Authors:  James S Duncan; Martin C Whittle; Kazuhiro Nakamura; Amy N Abell; Alicia A Midland; Jon S Zawistowski; Nancy L Johnson; Deborah A Granger; Nicole Vincent Jordan; David B Darr; Jerry Usary; Pei-Fen Kuan; David M Smalley; Ben Major; Xiaping He; Katherine A Hoadley; Bing Zhou; Norman E Sharpless; Charles M Perou; William Y Kim; Shawn M Gomez; Xin Chen; Jian Jin; Stephen V Frye; H Shelton Earp; Lee M Graves; Gary L Johnson
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

9.  Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.

Authors:  C E Ford; S K Lau; C Q Zhu; T Andersson; M S Tsao; W F Vogel
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

10.  Crystallographic insight into collagen recognition by discoidin domain receptor 2.

Authors:  Federico Carafoli; Dominique Bihan; Stavros Stathopoulos; Antonios D Konitsiotis; Marc Kvansakul; Richard W Farndale; Birgit Leitinger; Erhard Hohenester
Journal:  Structure       Date:  2009-12-09       Impact factor: 5.006

View more
  14 in total

1.  Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition.

Authors:  Minsoo Koh; Yunjung Woo; Rajeshwari R Valiathan; Hae Yoen Jung; So Yeon Park; Yong Nyun Kim; Hyeong-Reh Choi Kim; Rafael Fridman; Aree Moon
Journal:  Int J Cancer       Date:  2014-08-30       Impact factor: 7.396

2.  SUMOylation of HSP27 by small ubiquitin-like modifier 2/3 promotes proliferation and invasion of hepatocellular carcinoma cells.

Authors:  Haize Ge; Juan Du; Jingman Xu; Xiangliang Meng; Jinchuan Tian; Jie Yang; Huimin Liang
Journal:  Cancer Biol Ther       Date:  2017-06-30       Impact factor: 4.742

3.  Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.

Authors:  Zhen Wang; Yali Zhang; Sergio G Bartual; Jinfeng Luo; Tingting Xu; Wenting Du; Qiuju Xun; Zhengchao Tu; Rolf A Brekken; Xiaomei Ren; Alex N Bullock; Guang Liang; Xiaoyun Lu; Ke Ding
Journal:  ACS Med Chem Lett       Date:  2017-02-09       Impact factor: 4.345

Review 4.  Exploiting receptor tyrosine kinase co-activation for cancer therapy.

Authors:  Aik-Choon Tan; Simon Vyse; Paul H Huang
Journal:  Drug Discov Today       Date:  2016-07-21       Impact factor: 7.851

Review 5.  Advances in mass spectrometry based strategies to study receptor tyrosine kinases.

Authors:  Simon Vyse; Howard Desmond; Paul H Huang
Journal:  IUCrJ       Date:  2017-02-23       Impact factor: 4.769

Review 6.  Bioactive potential of natural biomaterials: identification, retention and assessment of biological properties.

Authors:  Kieran Joyce; Georgina Targa Fabra; Yagmur Bozkurt; Abhay Pandit
Journal:  Signal Transduct Target Ther       Date:  2021-03-19

7.  HMGB1 induces apoptosis and EMT in association with increased autophagy following H/R injury in cardiomyocytes.

Authors:  Fan Ouyang; He Huang; Mingyu Zhang; Mingxian Chen; Haobo Huang; Fang Huang; Shenghua Zhou
Journal:  Int J Mol Med       Date:  2016-01-29       Impact factor: 4.101

8.  Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.

Authors:  Zhen Wang; Huan Bian; Sergio G Bartual; Wenting Du; Jinfeng Luo; Hu Zhao; Shasha Zhang; Cheng Mo; Yang Zhou; Yong Xu; Zhengchao Tu; Xiaomei Ren; Xiaoyun Lu; Rolf A Brekken; Libo Yao; Alex N Bullock; Jin Su; Ke Ding
Journal:  J Med Chem       Date:  2016-06-03       Impact factor: 7.446

9.  Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1.

Authors:  Ji-Hyun Lee; Barun Poudel; Hyeon-Hui Ki; Sarmila Nepali; Young-Mi Lee; Jeon-Soo Shin; Dae-Ki Kim
Journal:  Sci Rep       Date:  2018-03-20       Impact factor: 4.379

10.  Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a]pyrazin-3-ylethynyl)-4-isopropyl- N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2.

Authors:  Zhen Wang; Yali Zhang; Daniel M Pinkas; Alice E Fox; Jinfeng Luo; Huocong Huang; Shengyang Cui; Qiuping Xiang; Tingting Xu; Qiuju Xun; Dongsheng Zhu; Zhengchao Tu; Xiaomei Ren; Rolf A Brekken; Alex N Bullock; Guang Liang; Ke Ding; Xiaoyun Lu
Journal:  J Med Chem       Date:  2018-08-20       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.